Results 271 to 280 of about 366,991 (303)

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Lancet, The, 2019
Avraham Eisbruch, Paul M Harari, Dukagjin Blakaj   +2 more
exaly  

Cisplatin see Etoposide/cisplatin

Reactions, 1988
openaire   +1 more source

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Lancet, The, 2016
Gérard Zalcman, Julien Mazieres, Laurent Greillier   +2 more
exaly  

[Cisplatin polyneuropathy].

Rivista di neurobiologia : organo ufficiale della Societa dei neurologi, neuroradiologi e neurochirurghi ospedalieri, 1984
Beghi, E, Bogliun, G, Crespi, V, Delodovici, M L, Landoni, F   +4 more
openaire   +2 more sources

Cisplatin see Bleomycin/cisplatin

Reactions, 1989
openaire   +1 more source

Cisplatin see Bleomycin/cisplatin/vinblastine

Reactions Weekly, 1990
openaire   +1 more source

MAST1 Drives Cisplatin Resistance in Human Cancers by Rewiring cRaf-Independent MEK Activation

Cancer Cell, 2018
Jaemoo Chun, Chaoyun Pan, Ruiting Lin
exaly  

Cisplatin see Bleomycin/cisplatin/etoposide

Reactions Weekly, 1991
openaire   +1 more source

Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours

Lancet, The, 1991
Gedske Daugaard
exaly  

Cisplatin see Bleomycin/cisplatin/etoposide

Reactions, 1989
openaire   +1 more source